We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a pivotal Phase 3 study of its kidney drug Filspari...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.91 | -3.50424328147 | 282.8 | 298.01 | 270.01 | 461629 | 281.08104331 | DE |
4 | -7.1 | -2.53580485017 | 279.99 | 380.01 | 160.01 | 611045 | 281.45071754 | DE |
12 | -18.07 | -6.21047566676 | 290.96 | 380.01 | 160.01 | 685610 | 285.99477879 | DE |
26 | 32.11 | 13.3358252347 | 240.78 | 380.01 | 154 | 686683 | 272.92805906 | DE |
52 | -28.36 | -9.41410788382 | 301.25 | 380.01 | 152 | 741912 | 273.37042859 | DE |
156 | 4.14 | 1.54046511628 | 268.75 | 400 | 0.11 | 743238 | 280.51743132 | DE |
260 | 69.89 | 34.4285714286 | 203 | 400 | 0.11 | 797966 | 279.54053694 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions